• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Minimum unit pricing on alcohol is associated with reductions in alcohol-related hospitalizations and mortality

byNeel MistryandTeddy Guo
May 10, 2023
in Chronic Disease, Gastroenterology
Reading Time: 2 mins read
Greater prenatal alcohol exposure trajectories linked to impaired growth and neurodevelopment
Share on FacebookShare on Twitter

1. Mortality attributable to alcohol consumption was reduced by 13.4% while hospitalizations were decreased by 4.1% after implementation of minimum unit pricing on alcoholic beverages.

2. Compared to the control group, the minimum unit pricing group reported fewer numbers of alcoholic liver disease and alcohol-related psychoses.

Evidence Rating Level: 3 (Average)

Study Rundown: Alcohol-related liver disease and mortality is a major cause for concern around the world. In May 2018, Scotland issued legislation that required a minimum of £0.50 per unit in an effort to minimize consumption. However, whether this has impacted long-term consumer health remains unclear. This randomized controlled trial aimed to assess the impact of minimum unit pricing (MUP) legislation on alcohol-related hospitalizations and deaths. The time series analysis followed alcohol consumers in Scotland over 32 months since legislation and used data from England to serve as the control group. According to study results, MUP legislation significantly decreased the number of alcohol-related hospitalizations and deaths in Scotland. Although this study was well-done, the control group was from England, as opposed to Scotland, which could affect the validity of data based on patient demographics.

Click to read the study in The Lancet

Relevant Reading: Alcohol Abstinence in Drinkers with Atrial Fibrillation

RELATED REPORTS

Seladelpar (Livdelzi) raises the bar for primary biliary cholangitis treatment

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

Limited pharmacotherapy initiation during veteran hospitalizations for alcohol use disorder

In-depth [case-control study]: This analysis time series ran from May 1, 2018, to Dec 31, 2020, across multiple hospitals in Scotland and the United Kingdom. The time frame prior to legislation implementation occurred between Jan 1, 2012, to April 30, 2018. Included were patients ≥ 16 years old with known alcohol consumption. The primary endpoint of mortality wholly attributable to alcohol consumption was reduced (13.4%, 95% confidence interval [CI] -18.4 to -8.3, p=0.0004) following MUP introduction in Scotland. Specifically, a substantial reduction was seen in deaths due to alcoholic liver disease (-11.7%, 95% CI -16.7 to 6.4, p<0.01) and alcohol dependence syndrome (-23.0%, 95% CI -36.9 to -6.0, p<0.01). A similar trend was noted for alcohol-related hospitalizations which decreased by 4.1% (95% CI -8.3 to 0.3, p=0.064). MUP legislation was also associated with a reduction in alcoholic liver disease (-9.8%, 95% CI -17.5 to -1.3, p=0.023) and psychoses (-7.2%, 95% CI -12.9 to -1.1, p=0.019). Overall, findings from this study suggest that MUP legislation was associated with a strong reduction in alcohol-related hospitalizations and mortality.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alcoholalcohol consumptionalcohol use disorderalcohol-associated liver diseasehepatologyliver diseaseminimum unit pricingsubstance use disorder
Previous Post

Genome-wide analysis aids in diagnosing rare pediatric diseases

Next Post

Venetoclax in addition to ibrutinib effective as a treatment for chronic lymphocytic leukemia

RelatedReports

Increased risk of stillbirth recurrence after a previous stillbirth
All Specialties

Seladelpar (Livdelzi) raises the bar for primary biliary cholangitis treatment

June 9, 2026
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Pharma

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

May 7, 2026
Increased risk of stillbirth recurrence after a previous stillbirth
Chronic Disease

Limited pharmacotherapy initiation during veteran hospitalizations for alcohol use disorder

May 4, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Pharma

2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options

May 4, 2026
Next Post
The CLL14 trial: longer progression-free survival for CLL patients with coexisting conditions treated with venetoclax

Venetoclax in addition to ibrutinib effective as a treatment for chronic lymphocytic leukemia

Fruit consumption among US youth differs by age, race

Wellness Check: Nutrition

No difference in outcomes after non-cardiac surgery with hypotension- versus hypertension-avoidance

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers
  • Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse
  • Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in